type : |
Artikel |
internetlink : |
http://www.ijpc.com/Abstracts/Abstract.cfm?ABS=3804 |
|
onderzoeksgroepen : |
Nablus - An-Najah National University, Faculty of Medicines and Health Sciences |
Auteur : |
Zaid Abdel Naser, Assali M, Qaddomi A, Ghanem M, Zaaror Yara Abu. |
titel : |
Preparation and Stability Evaluation of Extemporaneous Oral Suspension of Valsartan Using Commercially Available Tablets. |
Nummer : |
Int J Pharm Compound ; 18, 2 : 169-174. 2014 |
|
Niveau van bewijs : |
|
fysische stabiliteit : |
|
chemische stabiliteit : |
|
andere methoden : |
|
Reacties : |
|
Stoffenlijst
Valsartan
|
|
|
|
|
400 mg Valzan® (Pharmacare PLC) |
xanthaangom |
20 mg |
hydroxypropylcellulose |
20 mg |
Aerosil® |
110 mg |
bananensmaak |
20 mg |
Natriumfosfaat |
80 mg |
Titaandioxide |
1 mg |
aardbeiensmaak |
110 mg |
sucrose |
22,04 g |
gezuiverd water |
>> 25 mL |
|
23-27°C |
|
30 |
|
|
|
|
|
|
400 mg Valzan® (Pharmacare PLC) |
xanthaangom |
20 mg |
hydroxypropylcellulose |
20 mg |
Aerosil® |
110 mg |
bananensmaak |
20 mg |
Natriumfosfaat |
80 mg |
Titaandioxide |
1 mg |
aardbeiensmaak |
110 mg |
sucrose |
22,04 g |
gezuiverd water |
>> 25 mL |
|
38-42°C |
|
30 |
|
|
|
|
|